Concepedia

Helen Colquhoun

HC

Statistics

Publications

8

Citations

1.6K

H-Index

8

Active since

1995

Affiliations

Sage Therapeutics (United States)(Current)

Zucker Hillside Hospital

Northwell Health

University of North Carolina at Chapel Hill

Feinstein Institute for Medical Research

Helen Colquhoun is an author at Sage Therapeutics (United States) specializing in pharmacology, clinical pharmacology, and medicine.

Publications per year

1995–2022

8

Publications

8

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

Samantha Meltzer‐Brody, Helen Colquhoun, Robert Riesenberg et al. · The Lancet · 2018 · 782 citations

, , +8

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

Stephen Kanes, Helen Colquhoun, Handan Gunduz‐Bruce et al. · The Lancet · 2017 · 476 citations

, , +11

Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression

Stephen Kanes, Helen Colquhoun, James Doherty et al. · Human Psychopharmacology Clinical and Experimental · 2017 · 145 citations · Full text

, , +13

Brexanolone as adjunctive therapy in super‐refractory status epilepticus

Eric S. Rosenthal, Jan Claassen, Mark S. Wainwright et al. · Annals of Neurology · 2017 · 98 citations · Full text

, , +14

SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies

Ethan Hoffmann, George G. Nomikos, Inder Kaul et al. · Clinical Pharmacokinetics · 2019 · 58 citations · Full text

, , +15

1–5 of 8